Tivity Health (TVTY) Getting Positive Press Coverage, Study Finds

News stories about Tivity Health (NASDAQ:TVTY) have trended positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Tivity Health earned a daily sentiment score of 0.25 on Accern’s scale. Accern also gave news headlines about the company an impact score of 45.2010520209943 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Shares of Tivity Health (NASDAQ TVTY) opened at $37.75 on Wednesday. The stock has a market cap of $1,457.90, a PE ratio of 25.51, a P/E/G ratio of 1.90 and a beta of 0.25. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 0.02. Tivity Health has a 1 year low of $26.20 and a 1 year high of $48.50.

A number of equities analysts have recently issued reports on TVTY shares. Zacks Investment Research cut shares of Tivity Health from a “buy” rating to a “hold” rating in a research note on Thursday, December 28th. SunTrust Banks set a $50.00 price objective on shares of Tivity Health and gave the company a “buy” rating in a research note on Friday, October 27th. Chardan Capital reiterated a “neutral” rating and set a $44.00 target price (up previously from $40.00) on shares of Tivity Health in a research report on Friday, October 27th. Cantor Fitzgerald reiterated a “buy” rating and set a $45.00 target price on shares of Tivity Health in a research report on Monday, November 6th. Finally, BidaskClub cut shares of Tivity Health from a “buy” rating to a “hold” rating in a research report on Thursday, January 4th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Tivity Health presently has a consensus rating of “Buy” and an average price target of $45.25.

In related news, Director Conan Laughlin sold 490,000 shares of the stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $34.34, for a total transaction of $16,826,600.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 8.42% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another website, it was stolen and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/02/14/tivity-health-tvty-getting-positive-press-coverage-study-finds.html.

About Tivity Health

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Insider Buying and Selling by Quarter for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply